Skip to main content
Home
1L metastatic/recurrent NSCLC (with chemo)
1L metastatic/recurrent NSCLC
1L unresectable malignant pleural mesothelioma
1L advanced ccRCC
2L+ advanced HCC
Metastatic/unresectable melanoma
2L+ MSI-H/d-MMR metastatic/recurrent CRC
1L unresectable advanced/recurrent/metastatic ESCC
Skin cancer
Metastatic/unresectable melanoma
1
Skin cancer
Metastatic/unresectable melanoma
1
Click to zoom
IV, intravenous; QxW, every x weeks.
1. Opdivo
®
(nivolumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb; 2023.